Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 02/05/20191 min de leitura
Development of Antiviral Drugs for the Treatment of Adenoviral Infection in Immunocompromised Patients; Public Workshop; Request for Comments
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Development of Antiviral Drugs for the Treatment of Adenoviral Infection in Immunocompromised Patients." The purpose of the public workshop is to discuss the scientific and clinical trial design considerations for development of antiviral products to treat adenoviral infection.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →